Executive Series: Avita Medical (AVH) CEO, Dr Mike Perry

CommSec

Online Stockbroker

CommSec's Tom Piotrowski speaks with Avita Medical (AVH) CEO, Dr Mike Perry about:

  • Mike Perry’s recent appointment as CEO of AVH and the broader strategy that will guide the group over the medium term;
  • The key benefits of AVH’s ReCell product including early wound closure with less donor skin, better functional and cosmetic outcomes for improved quality of life, reduced hospital stay and a reduced need for reconstructive procedures and scar management;
  • The key milestones for AVH over the coming 18 months including the commercialisation of the ReCell product in the US;
  • The ongoing progress of the relationship with the US Biomedical Advanced Research and Development Authority (BARDA).

To view more Executive Series interviews, visit:

https://www.commsec.com.au/market-news/executive-series.html


1 stock mentioned

CommSec
CommSec
Online Stockbroker
Online Stockbroker

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

Expertise

No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment